A Pilot Study Evaluating the Safety, Tolerability and Efficacy of Gene Therapy With BBM-H901 in Hemophilia B Patients Aged 12-18 Years Old
Latest Information Update: 26 Feb 2025
At a glance
- Drugs Dalnacogene ponparvovec (Primary)
- Indications Haemophilia B
- Focus Adverse reactions
Most Recent Events
- 21 Nov 2023 Status changed from not yet recruiting to recruiting.
- 07 Feb 2023 New trial record